Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.

Xu J, Chen Y, Zhang R, Song Y, Cao J, Bi N, Wang J, He J, Bai J, Dong L, Wang L, Zhan Q, Abliz Z.

Mol Cell Proteomics. 2013 May;12(5):1306-18. doi: 10.1074/mcp.M112.022830. Epub 2013 Feb 8.

2.

Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.

Liu R, Peng Y, Li X, Wang Y, Pan E, Guo W, Pu Y, Yin L.

Int J Mol Sci. 2013 Apr 24;14(5):8899-911. doi: 10.3390/ijms14058899.

3.

Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.

Jin H, Qiao F, Chen L, Lu C, Xu L, Gao X.

J Proteome Res. 2014 Sep 5;13(9):4091-103. doi: 10.1021/pr500483z. Epub 2014 Aug 27.

PMID:
25162382
4.

Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy.

Ma H, Hasim A, Mamtimin B, Kong B, Zhang HP, Sheyhidin I.

World J Gastroenterol. 2014 Jul 14;20(26):8653-9. doi: 10.3748/wjg.v20.i26.8653.

5.

Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.

Tong YS, Wang XW, Zhou XL, Liu ZH, Yang TX, Shi WH, Xie HW, Lv J, Wu QQ, Cao XF.

Mol Cancer. 2015 Jan 21;14:3. doi: 10.1186/1476-4598-14-3.

6.

Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma.

Wang C, Li Q, Liu F, Chen X, Nesa EU, Guan S, Liu B, Han L, Tan B, Wang D, Chen P, Liu X, Zhang H, Sun Y, Cheng Y.

Biomarkers. 2016 Sep;21(6):517-22. doi: 10.3109/1354750X.2016.1160291. Epub 2016 May 6.

PMID:
27152453
7.

Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.

He FC, Meng WW, Qu YH, Zhou MX, He J, Lv P, Ming L.

World J Gastroenterol. 2015 Apr 21;21(15):4660-5. doi: 10.3748/wjg.v21.i15.4660.

8.

Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma.

Sun L, Dong S, Dong C, Sun K, Meng W, Lv P, Yin H, Ming L, He F.

Cancer Biomark. 2016;16(2):265-73. doi: 10.3233/CBM-150564.

PMID:
26756617
9.

LC-MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma.

Mir SA, Rajagopalan P, Jain AP, Khan AA, Datta KK, Mohan SV, Lateef SS, Sahasrabuddhe N, Somani BL, Keshava Prasad TS, Chatterjee A, Veerendra Kumar KV, VijayaKumar M, Kumar RV, Gundimeda S, Pandey A, Gowda H.

J Proteomics. 2015 Sep 8;127(Pt A):96-102. doi: 10.1016/j.jprot.2015.05.013. Epub 2015 May 14.

PMID:
25982385
10.
11.

Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.

Xu J, Chen Y, Zhang R, He J, Song Y, Wang J, Wang H, Wang L, Zhan Q, Abliz Z.

Sci Rep. 2016 Oct 11;6:35010. doi: 10.1038/srep35010.

12.

Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.

Jing R, Chen W, Wang H, Ju S, Cong H, Sun B, Jin Q, Chu S, Xu L, Cui M.

Am J Physiol Gastrointest Liver Physiol. 2015 Nov 1;309(9):G719-29. doi: 10.1152/ajpgi.00078.2015. Epub 2015 Aug 27.

13.

Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.

Łukaszewicz-Zając M, Mroczko B, Kozłowski M, Nikliński J, Laudański J, Szmitkowski M.

Dis Esophagus. 2012 Apr;25(3):242-9. doi: 10.1111/j.1442-2050.2011.01242.x. Epub 2011 Sep 2.

PMID:
21895853
14.

Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.

Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X, Zhang Y, Chen X, Wang J, Zen K, Zhang CY, Zhang C.

PLoS One. 2014 Mar 20;9(3):e92292. doi: 10.1371/journal.pone.0092292. eCollection 2014.

15.

Diagnostic and predictive significance of serum microRNA-7 in esophageal squamous cell carcinoma.

Dong W, Li B, Wang J, Song Y, Zhang Z, Fu C, Zhang P.

Oncol Rep. 2016 Mar;35(3):1449-56. doi: 10.3892/or.2015.4499. Epub 2015 Dec 21.

PMID:
26708917
16.

MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.

Guan S, Wang C, Chen X, Liu B, Tan B, Liu F, Wang D, Han L, Wang L, Huang X, Wang J, Yao B, Shi J, Chen P, Nesa EU, Song Q, Cheng Y.

Tumour Biol. 2016 Apr;37(4):4383-91. doi: 10.1007/s13277-015-4271-8. Epub 2015 Oct 24.

PMID:
26499784
17.

Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.

Zhang X, Xu L, Shen J, Cao B, Cheng T, Zhao T, Liu X, Zhang H.

Biochim Biophys Acta. 2013 Aug;1832(8):1207-16. doi: 10.1016/j.bbadis.2013.03.009. Epub 2013 Mar 20.

18.

Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma.

Hirajima S, Komatsu S, Ichikawa D, Takeshita H, Konishi H, Shiozaki A, Morimura R, Tsujiura M, Nagata H, Kawaguchi T, Arita T, Kubota T, Fujiwara H, Okamoto K, Otsuji E.

Br J Cancer. 2013 May 14;108(9):1822-9. doi: 10.1038/bjc.2013.148. Epub 2013 Apr 11.

19.

Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma.

Komatsu S, Ichikawa D, Hirajima S, Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Arita T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Yagi N, Otsuji E.

Br J Cancer. 2014 Oct 14;111(8):1614-24. doi: 10.1038/bjc.2014.451. Epub 2014 Aug 12.

20.

Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma.

Kijima T, Arigami T, Uchikado Y, Uenosono Y, Kita Y, Owaki T, Mori S, Kurahara H, Kijima Y, Okumura H, Maemura K, Ishigami S, Natsugoe S.

Cancer Sci. 2017 Feb;108(2):193-199. doi: 10.1111/cas.13127.

Supplemental Content

Support Center